While the Canadian Cardiovascular Society’s lipid guidelines recommend a once in a lifetime testing of Lp(a), there are no approved agents for lowering Lp(a) levels.
Low-dose ASA should not be routinely prescribed for the primary prevention of stroke, particularly in older persons predisposed to head trauma from falls.
Beyond providing a harmonized definition of death, guidelines present updated criteria for determining death in the event of devastating brain injury or circulatory arrest.